Agios Pharmaceuticals Inc (AGIO)
41.32
+0.76
(+1.89%)
USD |
NASDAQ |
Oct 04, 16:00
41.31
-0.02
(-0.04%)
After-Hours: 20:00
Agios Pharmaceuticals Shareholders Equity (Annual): 811.02M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 811.02M |
| December 31, 2022 | 1.101B |
| December 31, 2021 | 1.292B |
| December 31, 2020 | 399.50M |
| December 31, 2019 | 640.53M |
| December 31, 2018 | 687.54M |
| December 31, 2017 | 375.50M |
| Date | Value |
|---|---|
| December 31, 2016 | 358.59M |
| December 31, 2015 | 345.12M |
| December 31, 2014 | 424.37M |
| December 31, 2013 | 131.48M |
| December 31, 2012 | 43.90M |
| December 31, 2011 | 63.14M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
399.50M
Minimum
2020
1.292B
Maximum
2021
848.77M
Average
811.02M
Median
2023
Shareholders Equity (Annual) Benchmarks
| Pfizer Inc | 89.01B |
| Regeneron Pharmaceuticals Inc | 25.97B |
| Ligand Pharmaceuticals Inc | 700.91M |
| ADMA Biologics Inc | 135.21M |
| AnaptysBio Inc | 88.10M |